<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Harris CS</submitter><funding>NINR NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>596-607</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8726420</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(4)</volume><pubmed_abstract>The incorporation of omics approaches into symptom science research can provide researchers with information about the molecular mechanisms that underlie symptoms. Most of the omics analyses in symptom science have used a single omics approach. Therefore, these analyses are limited by the information contained within a specific omics domain (e.g., genomics and inherited variations, transcriptomics and gene function). A multi-staged data-integrated multi-omics (MS-DIMO) analysis integrates multiple types of omics data in a single study. With this integration, a MS-DIMO analysis can provide a more comprehensive picture of the complex biological mechanisms that underlie symptoms. The results of a MS-DIMO analysis can be used to refine mechanistic hypotheses and/or discover therapeutic targets</pubmed_abstract><journal>Biological research for nursing</journal><pubmed_title>Multi-Staged Data-Integrated Multi-Omics Analysis for Symptom Science Research.</pubmed_title><pmcid>PMC8726420</pmcid><funding_grant_id>CA107091</funding_grant_id><funding_grant_id>R37 CA233774</funding_grant_id><funding_grant_id>T32 NR016920</funding_grant_id><funding_grant_id>R01 CA107091</funding_grant_id><funding_grant_id>R01 CA118658</funding_grant_id><pubmed_authors>Harris CS</pubmed_authors><pubmed_authors>Cataldo J</pubmed_authors><pubmed_authors>Miaskowski CA</pubmed_authors><pubmed_authors>Kober KM</pubmed_authors><pubmed_authors>Dhruva AA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Multi-Staged Data-Integrated Multi-Omics Analysis for Symptom Science Research.</name><description>The incorporation of omics approaches into symptom science research can provide researchers with information about the molecular mechanisms that underlie symptoms. Most of the omics analyses in symptom science have used a single omics approach. Therefore, these analyses are limited by the information contained within a specific omics domain (e.g., genomics and inherited variations, transcriptomics and gene function). A multi-staged data-integrated multi-omics (MS-DIMO) analysis integrates multiple types of omics data in a single study. With this integration, a MS-DIMO analysis can provide a more comprehensive picture of the complex biological mechanisms that underlie symptoms. The results of a MS-DIMO analysis can be used to refine mechanistic hypotheses and/or discover therapeutic targets</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T12:04:47.319Z</modification><creation>2025-04-04T12:04:47.319Z</creation></dates><accession>S-EPMC8726420</accession><cross_references><pubmed>33827270</pubmed><doi>10.1177/10998004211003980</doi></cross_references></HashMap>